Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models.
about
Data on the anti-tumor effects of Selaginella tamariscina extract and amentoflavone combined with doxorubicin in mice.Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapyClick Chemistry in the Development of Contrast Agents for Magnetic Resonance Imaging.Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
P2860
Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models.
@en
type
label
Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models.
@en
prefLabel
Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models.
@en
P2860
P356
P1433
P1476
Bioorthogonal two-component drug delivery in HER2(+) breast cancer mouse models
@en
P2093
Dmitri Artemov
Sudath Hapuarachchige
P2860
P2888
P356
10.1038/SREP24298
P407
P577
2016-04-12T00:00:00Z